127 related articles for article (PubMed ID: 15904876)
1. Leptin inhibits apolipoprotein M transcription and secretion in human hepatoma cell line, HepG2 cells.
Luo G; Hurtig M; Zhang X; Nilsson-Ehle P; Xu N
Biochim Biophys Acta; 2005 May; 1734(2):198-202. PubMed ID: 15904876
[TBL] [Abstract][Full Text] [Related]
2. Effects of platelet-activating factor, tumor necrosis factor, and interleukin-1alpha on the expression of apolipoprotein M in HepG2 cells.
Xu N; Zhang XY; Dong X; Ekström U; Ye Q; Nilsson-Ehle P
Biochem Biophys Res Commun; 2002 Apr; 292(4):944-50. PubMed ID: 11944906
[TBL] [Abstract][Full Text] [Related]
3. Transforming growth factor-beta down-regulates apolipoprotein M in HepG2 cells.
Xu N; Hurtig M; Zhang XY; Ye Q; Nilsson-Ehle P
Biochim Biophys Acta; 2004 Jul; 1683(1-3):33-7. PubMed ID: 15238217
[TBL] [Abstract][Full Text] [Related]
4. Both leptin and leptin-receptor are essential for apolipoprotein M expression in vivo.
Xu N; Nilsson-Ehle P; Hurtig M; Ahrén B
Biochem Biophys Res Commun; 2004 Sep; 321(4):916-21. PubMed ID: 15358114
[TBL] [Abstract][Full Text] [Related]
5. Down-regulation of apolipoprotein M expression is mediated by phosphatidylinositol 3-kinase in HepG2 cells.
Xu N; Ahrén B; Jiang J; Nilsson-Ehle P
Biochim Biophys Acta; 2006 Feb; 1761(2):256-60. PubMed ID: 16542871
[TBL] [Abstract][Full Text] [Related]
6. Opposing effects of apolipoprotein m on catabolism of apolipoprotein B-containing lipoproteins and atherosclerosis.
Christoffersen C; Pedersen TX; Gordts PL; Roebroek AJ; Dahlbäck B; Nielsen LB
Circ Res; 2010 May; 106(10):1624-34. PubMed ID: 20360257
[TBL] [Abstract][Full Text] [Related]
7. Estrogen upregulates hepatic apolipoprotein M expression via the estrogen receptor.
Wei J; Shi Y; Zhang X; Feng Y; Luo G; Zhang J; Mu Q; Tang Y; Yu Y; Pan L; Nilsson-Ehle P; Xu N
Biochim Biophys Acta; 2011 Dec; 1811(12):1146-51. PubMed ID: 21816233
[TBL] [Abstract][Full Text] [Related]
8. Dihydrotestosterone regulating apolipoprotein M expression mediates via protein kinase C in HepG2 cells.
Yi-zhou Y; Bing C; Ming-qiu L; Wei W; Ru-xing W; Jun R; Liu-yan W; Zhao-hui J; Yong J; Guo qing J; Jian Z
Lipids Health Dis; 2012 Dec; 11():168. PubMed ID: 23216709
[TBL] [Abstract][Full Text] [Related]
9. Hyperglycemia down-regulates apolipoprotein M expression in vivo and in vitro.
Zhang X; Jiang B; Luo G; Nilsson-Ehle P; Xu N
Biochim Biophys Acta; 2007 Jul; 1771(7):879-82. PubMed ID: 17556016
[TBL] [Abstract][Full Text] [Related]
10. Hyperglycemia-induced downregulation of apolipoprotein M expression is not via the hexosamine pathway.
Jiang B; Zhang X; Di D; Luo G; Shi Y; Zhang J; Berggren-Söderlund M; Nilsson-Ehle P; Xu N
Lipids Health Dis; 2015 Sep; 14():110. PubMed ID: 26377577
[TBL] [Abstract][Full Text] [Related]
11. Vascular endothelial growth factor downregulates apolipoprotein M expression by inhibiting Foxa2 in a Nur77-dependent manner.
Hu YW; Zheng L; Wang Q; Zhong TY; Yu X; Bao J; Cao NN; Li B; Si-Tu B
Rejuvenation Res; 2012 Aug; 15(4):423-34. PubMed ID: 22877565
[TBL] [Abstract][Full Text] [Related]
12. Increased mRNA levels of apolipoprotein M and apolipoprotein AI in the placental tissues with fetal macrosomia.
Yu Y; Luo GH; Zhang J; Jiang H; Wei J; Shi YP; Zhang XY; Xu N
Arch Gynecol Obstet; 2015 Feb; 291(2):299-303. PubMed ID: 25194312
[TBL] [Abstract][Full Text] [Related]
13. Liver X receptor agonist downregulates hepatic apoM expression in vivo and in vitro.
Zhang X; Zhu Z; Luo G; Zheng L; Nilsson-Ehle P; Xu N
Biochem Biophys Res Commun; 2008 Jun; 371(1):114-7. PubMed ID: 18413148
[TBL] [Abstract][Full Text] [Related]
14. Characterization of apoM in normal and genetically modified mice.
Faber K; Axler O; Dahlbäck B; Nielsen LB
J Lipid Res; 2004 Jul; 45(7):1272-8. PubMed ID: 15102887
[TBL] [Abstract][Full Text] [Related]
15. Apolipoprotein M.
Luo G; Zhang X; Nilsson-Ehle P; Xu N
Lipids Health Dis; 2004 Oct; 3():21. PubMed ID: 15461812
[TBL] [Abstract][Full Text] [Related]
16. Effect of simvastatin on the expression and regulation mechanism of apolipoprotein M.
Yang L; Zhao S
Int J Mol Med; 2012 Mar; 29(3):510-4. PubMed ID: 22160096
[TBL] [Abstract][Full Text] [Related]
17. Apolipoprotein M: Research progress, regulation and metabolic functions (Review).
Huang LZ; Gao JL; Pu C; Zhang PH; Wang LZ; Feng G; Zhang Y
Mol Med Rep; 2015 Aug; 12(2):1617-24. PubMed ID: 25901639
[TBL] [Abstract][Full Text] [Related]
18. ACTH decreases the expression and secretion of apolipoprotein B in HepG2 cell cultures.
Xu N; Ekstrom U; Nilsson-Ehle P
J Biol Chem; 2001 Oct; 276(42):38680-4. PubMed ID: 11514556
[TBL] [Abstract][Full Text] [Related]
19. TGF-β Down-regulates Apolipoprotein M Expression through the TAK-1-JNK-c-Jun Pathway in HepG2 Cells.
Ren K; Mo ZC; Liu X; Tang ZL; Jiang Y; Peng XS; Zhang QH; Shi JF; Yi GH
Lipids; 2017 Feb; 52(2):109-117. PubMed ID: 28039587
[TBL] [Abstract][Full Text] [Related]
20. Palmitic acid suppresses apolipoprotein M gene expression via the pathway of PPARβ/δ in HepG2 cells.
Luo G; Shi Y; Zhang J; Mu Q; Qin L; Zheng L; Feng Y; Berggren-Söderlund M; Nilsson-Ehle P; Zhang X; Xu N
Biochem Biophys Res Commun; 2014 Feb; 445(1):203-7. PubMed ID: 24508264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
